Invitrogen, ABI, Xenex, BD, Scanalytics, Tm Bioscience, CombiMatrix, NCI, Synthetic Genomics | GenomeWeb

Invitrogen Is First Licensee Under ABI's
Expanded PCR Licensing Program

Applied Biosystems has granted the first license under its new expanded PCR-licensing program to Invitrogen, ABI said this week.

The expanded program includes patents for real-time PCR and other PCR-related technology not licensed under Applied Biosystems' previous PCR-licensing program, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.